ADVFN - Advanced Financial Network.
HOME» NASDAQ » A » AMGN Stock Price » AMGN Stock News

Amgen Inc. Share News

 Amgen Inc. (mm) Stock Price
AMGN Stock Price
 Amgen Inc. (mm) Stock Chart
AMGN Stock Chart
 Amgen Inc. (mm) Stock News
AMGN Stock News
 Amgen Inc. (mm) Company Information
AMGN Company Information
 Amgen Inc. (mm) Stock Trades
AMGN Stock Trades

WSJ BLOG/Health: A.M. Vitals: Health-Care Overhaul Case Ripples Outward

(This story has been posted on The Wall Street Journal Online's Health Blog at http://blogs.wsj.com/health.) By Mark Long Here's what's making health news this morning: Health Case Ripples Outward (WSJ): After three days of arguments over the constitutionality of the health-care overhaul, it's impossible to predict how the Supreme Court will rule, but skepticism from some justices heightens the possibility it could be overturned in June. Also: Three Days of Hearings Yield Five Take-Aways. Obesity-Linked Cancers Increase (WSJ): Overall cancer diagnoses in the U.S. have dropped, but several cancers linked to obesity and a sedentary lifestyle have risen each year from 1999 through 2008. Cancer: 'Book of Knowledge' Published (BBC): A large "encyclopedia" detailing how hundreds of different cancer cell lines interact with drugs that could speed development of new treatments was published in Nature. In Cancer Science, Many "Discoveries" Don't Hold Up (Reuters): Forty-seven of 53 "landmark" cancer studies from reputable labs couldn't be replicated, the former head of cancer research for Amgen said in a commentary piece in Nature, dimming the prospects for new drug development. FDA Asks Chelsea Therapeutics for More Data on Northera (Dow Jones Newswires): The FDA declined to approve Northera, a low-blood-pressure drug from Chelsea Therapeutics, saying additional data showing efficacy was required. Image source: iStockphoto -For continuously updated news from The Wall Street Journal, see WSJ.com at http://wsj.com.

Stock News for Amgen Inc. (AMGN)
DateTimeHeadline
01/17/201710:00:00deCODE Study Shows that Variants in the Sequence of the Genome...
01/17/201705:00:00deCODE Study Shows that Variants in the Sequence of the Genome...
01/13/201717:17:58Post-effective Amendment to an S-8 Filing (s-8 Pos)
01/13/201717:11:28Post-effective Amendment to an S-8 Filing (s-8 Pos)
01/13/201716:21:00Supreme Court to Weigh How Soon Firms Can Sell Copycat Biotech...
01/10/201716:12:00Study Results Published in the Journal of the American Medical...
01/09/201718:21:00Amgen Statement on January 9, 2017, U.S. District Court Decision
01/09/201706:12:09Current Report Filing (8-k)
01/09/201706:00:00Amgen And DaVita Enter Into New Sourcing And Supply Agreement
01/09/201704:00:00Amgen and Immatics Enter Strategic Collaboration to Develop Novel...
01/06/201714:29:00Sanofi Investors Count Cost of Praluent Ruling -- Update
01/06/201708:41:00Sanofi Investors Count Cost of Praluent Ruling
01/06/201703:02:00Sanofi Loses Patent Case -- WSJ
01/05/201721:34:00Court Grants Permanent Injunction For Infringement Of Amgen's...
01/05/201721:07:00Judge Rules Against Sanofi and Regeneron in Patent Case -- Update
01/05/201720:25:00Judge Rules Against Sanofi and Regeneron in Patent Case
01/04/201716:00:00Amgen To Present At The 35th Annual J.P. Morgan Healthcare Conference
12/22/201619:27:00Donald Trump's Pick for Health Secretary Traded Medical Stocks...
12/20/201616:20:00Amgen Announces 15 Percent Increase In 2017 First Quarter Dividend
12/19/201619:00:00Amgen And UCB Announce Submission Of Application For Investigational...

Amgen Inc. and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2016 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US